Next Article in Journal
Diabetes Management in Danish Primary School: A Survey of Experiences of Parents of Children with Type 1 Diabetes
Next Article in Special Issue
Frailty in Older Patients with End-Stage Renal Disease and Undergoing Chronic Haemodialysis in Vietnam
Previous Article in Journal
Managing Hospitalized Patients Taking SGLT2 Inhibitors: Reducing the Risk of Euglycemic Diabetic Ketoacidosis
Previous Article in Special Issue
Knowledge of Diabetes among Adults at High Risk for Type 2 Diabetes in the Trivandrum District of Kerala, India
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diabetology
Volume 4
Issue 1
10.3390/diabetology4010011
diabetology-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Achieving Remission in the Era of Clinical Inertia: What Is Preventing Us from Treating Type 2 Diabetes?

by
Austen Suits
,
Ridhi Gudoor
and
Jay H. Shubrook
*
College of Osteopathic Medicine, Touro University California, Vallejo, CA 94592, USA
*
Author to whom correspondence should be addressed.
Diabetology 2023, 4(1), 93-107; https://doi.org/10.3390/diabetology4010011
Submission received: 7 January 2023 / Revised: 5 February 2023 / Accepted: 10 February 2023 / Published: 24 February 2023
(This article belongs to the Special Issue Exclusive Papers Collection of Editorial Board Members in Diabetology)
Browse Figures
Review Reports Versions Notes

Abstract

Despite evolution in treatment options and improved understanding of pathophysiology, the treatment of type 2 diabetes remains unsatisfactory. Current management guidelines complicated by clinical inertia have resulted in over half of patients failing to meet glycemic targets. Expert consensus has defined a state of diabetes remission whereby treatment can induce sustained normalization of glucose levels. Evidence suggests that metabolic surgery, intensive lifestyle modification, and pharmacologic approaches are each viable options for achieving remission when implemented early in the disease course. The authors review each of these strategies and include practical considerations to aid in the pursuit of remission.
Keywords: diabetes; clinical inertia; remission diabetes; clinical inertia; remission

Share and Cite

MDPI and ACS Style

Suits, A.; Gudoor, R.; Shubrook, J.H. Achieving Remission in the Era of Clinical Inertia: What Is Preventing Us from Treating Type 2 Diabetes? Diabetology 2023, 4, 93-107. https://doi.org/10.3390/diabetology4010011

AMA Style

Suits A, Gudoor R, Shubrook JH. Achieving Remission in the Era of Clinical Inertia: What Is Preventing Us from Treating Type 2 Diabetes? Diabetology. 2023; 4(1):93-107. https://doi.org/10.3390/diabetology4010011

Chicago/Turabian Style

Suits, Austen, Ridhi Gudoor, and Jay H. Shubrook. 2023. "Achieving Remission in the Era of Clinical Inertia: What Is Preventing Us from Treating Type 2 Diabetes?" Diabetology 4, no. 1: 93-107. https://doi.org/10.3390/diabetology4010011

APA Style

Suits, A., Gudoor, R., & Shubrook, J. H. (2023). Achieving Remission in the Era of Clinical Inertia: What Is Preventing Us from Treating Type 2 Diabetes? Diabetology, 4(1), 93-107. https://doi.org/10.3390/diabetology4010011

Article Metrics

Back to TopTop